Citadel Advisors’s Entero Therapeutics ENTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.97K | Buy |
+4,138
| New | +$4.97K | ﹤0.01% | 5694 |
|
|
2024
Q4 | – | Sell |
-3,351
| Closed | -$3.46K | – | 6929 |
|
|
2024
Q3 | $3.46K | Buy |
+3,351
| New | +$3.46K | ﹤0.01% | 5541 |
|
|
2023
Q4 | – | Sell |
-1,364
| Closed | -$23.7K | – | 6792 |
|
|
2023
Q3 | $23.7K | Buy |
+1,364
| New | +$23.7K | ﹤0.01% | 5274 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | -$20K | – | 7249 |
|
|
2021
Q4 | $20K | Buy |
+1
| New | +$20K | ﹤0.01% | 6319 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | -$141K | – | 7216 |
|
|
2021
Q2 | $141K | Buy |
+1
| New | +$141K | ﹤0.01% | 5780 |
|
|
2020
Q2 | – | Hold |
0
| – | -$7K | – | 5398 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4765 |
|